TY - JOUR
T1 - Urine fingerprinting
T2 - Detection of sample tampering in an opiate dependency program
AU - Kapur, Bhushan
AU - Hershkop, Sheldon
AU - Koren, Gideon
AU - Gaughan, Victor
PY - 1999/4
Y1 - 1999/4
N2 - Methadone treatment programs commonly monitor patient compliance by screening urine samples for drugs of abuse. Our experience suggests that re- submission of urine samples (for example, providing a urine sample that is either not that of the patient or was previously submitted) is often used as a method of sample tampering. We have developed an algorithm that combines urine sodium, chloride, creatinine and pH values with urine drug screening results to effectively detect resubmitted samples. Given the widespread use of urine drug screening in drug and alcohol rehabilitation programs, we believe this technique has significant practical benefits. This technique may also have an application in forensic identification of duplicate samples.
AB - Methadone treatment programs commonly monitor patient compliance by screening urine samples for drugs of abuse. Our experience suggests that re- submission of urine samples (for example, providing a urine sample that is either not that of the patient or was previously submitted) is often used as a method of sample tampering. We have developed an algorithm that combines urine sodium, chloride, creatinine and pH values with urine drug screening results to effectively detect resubmitted samples. Given the widespread use of urine drug screening in drug and alcohol rehabilitation programs, we believe this technique has significant practical benefits. This technique may also have an application in forensic identification of duplicate samples.
KW - Opiate dependency programs
KW - Sample tampering
KW - Urine fingerprinting
UR - http://www.scopus.com/inward/record.url?scp=0032951739&partnerID=8YFLogxK
U2 - 10.1097/00007691-199904000-00017
DO - 10.1097/00007691-199904000-00017
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 10217347
AN - SCOPUS:0032951739
SN - 0163-4356
VL - 21
SP - 243
EP - 250
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
IS - 2
ER -